This is the authors' abstract. We don't add key points for this paper.
In order to obtain antineoplastic compounds and innovative formulations, new technologies and testing methods are continuously being developed. Unfortunately, besides cancer cells, chemotherapy also affects normal cells. An option to avoid toxicity is represented by the targeted cancer treatment using novel pharmaceutical dosage forms. Liposomes represent a relatively new pharmaceutical dosage form, used for their many advantages. In this article, the methods of liposomal preparation are mentioned, along with the classification and the latest improvements involving this pharmaceutical form. The bioavailability of conventional liposomes is currently improved by developing photodynamic liposomes, pH or temperature sensitive liposomes and targeted liposomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sevastre et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: